SCHEMBL23529285

SCHEMBL23529285

CC(C)(C)C1CN(Cc2cc(=O)n(Cc3ccccc3)cn2)CCN1C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 1/20 0.39
▸ HTR7 P34969 1/20 0.39
▸ PTGDR2 Q9Y5Y4 3/20 0.36
▸ USP7 Q93009 1/20 0.36
▸ AGTR2 P50052 1/20 0.36
▸ CYP11B2 P19099 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ BRD2 P25440 1/20 0.35
▸ BRD3 Q15059 1/20 0.35
▸ BRDT Q58F21 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.35
▸ CHRM4 P08173 1/20 0.35
▸ CYP2D6 P10635 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ SLC6A7 Q99884 1/20 0.34
▸ ACHE P22303 1/20 0.34
▸ MGLL Q99685 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3773661 0.82 AGTR2 (0.50) AGTR2KDM4EACHE
SCHEMBL23529287 0.77 PTGS1 (0.41) AGTR2CHRM4
SCHEMBL23529286 0.76 OPRD1 (0.50) BRD4CHRM4KDM4EACHE
SCHEMBL21996912 0.73 S1PR5 (0.40) PTGDR2AGTR2HRH3MGLL
SCHEMBL23922806 0.73 SMN1; SMN2 (0.48) PKMKDM4E
SCHEMBL5386962 0.73 DRD2 (0.41) AGTR2CYP2D6KDM4E
SCHEMBL23535924 0.72 CYP11B2 (0.38) CYP11B2HRH3KDM4E
SCHEMBL211059 0.72 DRD2 (0.43) PTGDR2AGTR2GAAHRH3KDM4E
SCHEMBL21997577 0.72 CA2 (0.42) PTGDR2AGTR2GAAHRH3KDM4E
SCHEMBL25317215 0.72 LMNA (0.46) PTGDR2AGTR2GAAMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021127273-A1 1 -((6-OXO-1,6-DIHYDROPYRIDAZIN-4-YL)METHYL)PIPERAZINE AND 1 -((6-OXO-1,6-DIHYDROPYRIMIDIN-4-YL)METHYL)PIPERAZINE DERIVATIVES AS PROLYL HYDROXYLASE, HIF-1 ALPHA AND PGK MODULATORS FOR USE IN TREATING INFLAMMATORY DISEASES, CANCER OR INFECTIONS GB004, INC. (US) 2021-06-24 — — WO disclosed
Send feedback